外泌體研究產品市場規模、佔有率和成長分析（按產品、適應症、應用、製造服務、最終用戶和地區）- 產業預測，2025-2032 年

全球外泌體研究產品市場規模預計將在 2023 年達到 1.5579 億美元，從 2024 年的 1.8056 億美元成長到 2032 年的 5.8788 億美元，預測期內（2025-2032 年）的複合年成長率為 15.9%。

由於學術研究機構、製藥和生物技術公司、醫院和臨床試驗的興趣日益濃厚，外泌體研究產品市場正在經歷顯著成長。外泌體研究需求的激增是由其診斷潛力和作為細胞間通訊者的新興角色所推動的。截至 2022 年，全球有超過 6,000 種物質正在接受臨床試驗測試，醫藥品研究開發費用成長驚人，達到 68%，市場勢頭強勁。世界衛生組織 (WHO) 強調，癌症相關死亡人數呈現驚人成長，到 2020 年將達到近 1,000 萬人，促使研究人員尋找用於癌症檢測的生物標記。再加上心血管疾病和類風濕性關節炎等慢性病發病率的上升，對藥品的需求可能在未來幾年推動外泌體研究產品市場的進一步成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析

外泌體研究產品市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 套件和試劑
  • 抗體
  • 分離精製定量套件試劑
  • 其他套件和試劑
• 裝置
• 服務

外泌體研究產品市場規模（按適應症和複合年成長率） (2025-2032)

• 市場概況
• 癌症適應症
  • 肺癌
  • 乳癌
  • 攝護腺癌
  • 大腸直腸癌
  • 其他癌症
• 神經退化性疾病
• 心血管疾病
• 感染疾病
• 其他疾病

外泌體研究產品市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 生物標記
• 疫苗研發
• 組織再生
• 其他用途

外泌體研究產品市場規模依製造服務及複合年成長率 (2025-2032)

• 市場概況
• 幹細胞來源的外泌體製造服務
• 樹突細胞來源的外泌體製造服務
• 其他製造服務

外泌體研究產品市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 學術研究所
• 製藥和生物技術公司
• 醫院和臨床實驗室

外泌體研究產品市場規模（按地區和複合年成長率） (2025-2032)

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（United States）
• QIAGEN NV（Germany）
• Lonza Group Ltd.（Switzerland）
• Miltenyi Biotec（Germany）
• Key Developments
• Danaher Corporation（United States）
• Hologic Inc.（United States）
• Fujifilm Holdings Corporation（Japan）
• Hitachi Chemical Diagnostics Inc.（Japan）
• MBL International（United States）
• Novus Biologicals（United States）
• System Biosciences（SBI）（United States）
• NanoSomix Inc.（United States）
• Norgen Biotek Corp.（Canada）
• AMS Biotechnology（Europe）Limited（United Kingdom）
• Aethlon Medical Inc.（United States）
• Capricor Therapeutics Inc.（United States）
• Creative Medical Technology Holdings Inc.（United States）
• Evox Therapeutics Ltd.（United Kingdom）

結論和建議

Global Exosome Research Products Market size was valued at USD 155.79 million in 2023 and is poised to grow from USD 180.56 million in 2024 to USD 587.88 million by 2032, growing at a CAGR of 15.9% during the forecast period (2025-2032).

The exosome research products market is witnessing significant growth driven by heightened interest from academic research institutes, pharmaceutical and biotechnology companies, hospitals, and clinical trials. The surge in demand for exosome studies stems from their diagnostic potential and emerging role as intercellular communicators. With over 6,000 substances tested globally in clinical trials-an impressive 68% rise in pharmaceutical R&D spending as of 2022-the market's momentum is strong. The World Health Organization has highlighted the alarming rise in cancer-related deaths, with nearly 10 million in 2020, further pressing researchers to identify biomarkers for cancer detection. Coupled with the rising incidence of chronic diseases, including cardiovascular issues and rheumatoid arthritis, the demand for pharmaceutical drugs is set to propel further growth in the exosome research products market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Exosome Research Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Exosome Research Products Market Segments Analysis

Global Exosome Research Products Market is segmented by Product, Indication, Application, Manufacturing Service, End User and Region. Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Indication, the market is segmented into Cancer Indication, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases and Other Diseases. Based on Application, the market is segmented into Biomarkers, Vaccine Development, Tissue Regeneration and Other applications. Based on Manufacturing Service, the market is segmented into Stem cell-derived exosome manufacturing services, Dendritic cell-derived exosome manufacturing services and Other manufacturing services. Based on End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and Hospitals & Clinical Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Exosome Research Products Market

The growing recognition of exosomes as crucial components in intercellular communication, biomarker identification, and understanding disease mechanisms is significantly boosting interest in exosome-related products. Researchers are delving into the versatile applications of exosomes for diagnostics, therapeutic solutions, and drug delivery systems. This heightened focus on the potential of exosomes as valuable tools in various biomedical fields is driving an increasing demand for research products specifically designed for exosome studies. As the significance of exosomes continues to be acknowledged, the global market for exosome research products is set to expand, reflecting the ongoing advancements in scientific exploration and innovation.

Restraints in the Global Exosome Research Products Market

The Global Exosome Research Products market faces significant challenges due to the substantial heterogeneity of exosomes in terms of their size, composition, and cargo. This variability complicates their isolation, characterization, and functional analysis. Furthermore, the intricate nature of exosome biology, combined with the absence of standardized protocols, can hinder reproducibility and complicate data interpretation in exosome studies. These factors collectively present obstacles for researchers, impacting their ability to draw consistent and reliable conclusions, thus restraining progress in the field and potentially limiting market growth for exosome research products.

Market Trends of the Global Exosome Research Products Market

The global exosome research products market is witnessing a significant trend towards the adoption of advanced isolation and analytical technologies. Researchers are increasingly focused on developing sophisticated methods to isolate exosomes from complex biological samples, such as blood, urine, and tissue fluids, ensuring high purity and yield. This trend is driven by a rising demand for integrated systems that facilitate comprehensive characterization and functional analysis of exosomes, encompassing their delivery molecules, surface markers, and biological activities. As the scientific community strives for more precision in exosome research, the market is expected to expand, fostering innovation and enhancing product offerings.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Exosome Research Products Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
  • Antibodies
  • Isolation, Purification, Quantitation Kits, and reagents
  • Other kits & reagents
• Instruments
• Services

Global Exosome Research Products Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Cancer Indication
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Other Cancers
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Other Diseases

Global Exosome Research Products Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomarkers
• Vaccine Development
• Tissue Regeneration
• Other applications

Global Exosome Research Products Market Size by Manufacturing Service & CAGR (2025-2032)

• Market Overview
• Stem cell-derived exosome manufacturing services
• Dendritic cell-derived exosome manufacturing services
• Other manufacturing services

Global Exosome Research Products Market Size by End User & CAGR (2025-2032)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Laboratories

Global Exosome Research Products Market Size & CAGR (2025-2032)

• North America (Product & Service, Indication, Application, Manufacturing Service, End User)
  • US
  • Canada
• Europe (Product & Service, Indication, Application, Manufacturing Service, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Indication, Application, Manufacturing Service, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Indication, Application, Manufacturing Service, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Indication, Application, Manufacturing Service, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Chemical Diagnostics Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MBL International (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus Biologicals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (SBI) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoSomix Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMS Biotechnology (Europe) Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aethlon Medical Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capricor Therapeutics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Medical Technology Holdings Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evox Therapeutics Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations